Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial transitional cell carcinoma

L A Kiemeney1, M Schoenberg

  • 1James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

The Journal of Urology
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.

Health and quality of life outcomes·2022
Same author

Role of multidisciplinary team meetings in implementation of chemohormonal therapy in metastatic prostate cancer in daily practice.

Prostate cancer and prostatic diseases·2022
Same author

Corrigendum to "Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study".

Urologic oncology·2022
Same author

Histopathological re-evaluations of biopsies in prostate cancer: a nationwide observational study.

Scandinavian journal of urology·2020
Same author

Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study.

Urologic oncology·2020
Same author

Insight into bladder cancer care: study protocol of a large nationwide prospective cohort study (BlaZIB).

BMC cancer·2020

Familial bladder cancer suggests a genetic predisposition, with first-degree relatives having double the risk. Further research is needed to identify specific genes involved in this inherited form of transitional cell carcinoma.

Area of Science:

  • Urology
  • Oncology
  • Genetics

Background:

  • Bladder cancer is a prevalent malignancy with largely unknown causes beyond smoking and occupational exposures.
  • Understanding familial bladder cancer may illuminate the pathogenesis of this disease.
  • While most patients lack a family history, studying familial cases is crucial.

Purpose of the Study:

  • To review and synthesize current knowledge on familial transitional cell carcinoma.
  • To evaluate evidence for a genetic component in bladder cancer inheritance.

Main Methods:

  • Literature review of case reports.
  • Analysis of epidemiological studies on familial bladder cancer.

Main Results:

Related Experiment Videos

  • Case reports show clustering of bladder cancer within families, often with early disease onset, suggesting a genetic link.
  • Epidemiological studies indicate a twofold increased risk for first-degree relatives.
  • Familial clustering of smoking habits does not explain the elevated risk.
  • Conclusions:

    • Familial bladder cancer likely involves a genetically transmitted predisposition in some families.
    • Identification of candidate genes is necessary for further understanding and potential therapeutic targets.